Unknown

Dataset Information

0

Early treatment with inhaled budesonide to prevent clinical deterioration in patients with COVID-19.

ABSTRACT:

SUBMITTER: Agusti A 

PROVIDER: S-EPMC8040539 | biostudies-literature | 2021 Jul

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Early treatment with inhaled budesonide to prevent clinical deterioration in patients with COVID-19.

Agusti Alvar A   Torres Ferran F   Faner Rosa R  

The Lancet. Respiratory medicine 20210409 7

Similar Datasets

Unknown Add-on inhaled budesonide in the treatment of hospitalised patients with COVID-19: a randomised clinical trial.
| S-EPMC8832375 | biostudies-literature
Unknown Oral Fluvoxamine With Inhaled Budesonide for Treatment of Early-Onset COVID-19 : A Randomized Platform Trial.
| S-EPMC10111398 | biostudies-literature
Unknown Early treatment with fluvoxamine, bromhexine, cyproheptadine, and niclosamide to prevent clinical deterioration in patients with symptomatic COVID-19: a randomized clinical trial.
| S-EPMC10955208 | biostudies-literature
Unknown Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial.
| S-EPMC8040526 | biostudies-literature
Unknown Prognostic Accuracy of Early Warning Scores for Clinical Deterioration in Patients With COVID-19.
| S-EPMC7882600 | biostudies-literature
Unknown Multicenter validation of Early Warning Scores for detection of clinical deterioration in COVID-19 hospitalized patients.
| S-EPMC9579896 | biostudies-literature
Unknown [Multicenter validation of Early Warning Scores for detection of clinical deterioration in COVID-19 hospitalized patients].
| S-EPMC8629741 | biostudies-literature
Unknown Budesonide: A promising candidate therapeutic for early COVID-19.
| S-EPMC8327609 | biostudies-literature
Unknown RIC in COVID-19-a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19.
| S-EPMC8225459 | biostudies-literature
Unknown Exposure-Response and Clinical Outcome Modeling of Inhaled Budesonide/Formoterol Combination in Asthma Patients.
| S-EPMC7238265 | biostudies-literature